Kazia Therapeutics (KZIA) Tax Rate (2009 - 2011)

Kazia Therapeutics (KZIA) posted Tax Rate of 0.65% for Q4 2011, up 239.5% on a QoQ basis from 0.19% in Q4 2010, and up 46.0% year-over-year from 0.45% in Q4 2010.

Kazia Therapeutics (KZIA) has 3 years of Tax Rate data on file, last reported at 0.65% in Q4 2011.

  • In Q4 2011, Tax Rate rose 46.0% year-over-year to 0.65%; the TTM figure through Dec 2011 stood at 262.55% (down 13341.0% YoY), while the FY2025 annual figure was 7.78%, up 678.0% from the prior year.
  • Tax Rate improved to 0.65% in Q4 2011, from 0.19% in the prior quarter.
  • Across five years, Tax Rate topped out at 0.65% in Q4 2011 and bottomed at 0.02% in Q4 2009.
  • A 3-year average of 0.29% and a median of 0.19% in 2010 frame the typical range for Tax Rate.
  • Annual changes were most pronounced in 2010 — Tax Rate climbed 18 bps — and 2011, when it surged 46 bps.
  • Year by year, Tax Rate stood at 0.02% in 2009, then surged by 1126 bps to 0.19% in 2010, then surged by 240 bps to 0.65% in 2011.
  • The last three Tax Rate figures came in at 0.65% (Q4 2011), 0.19% (Q4 2010), and 0.02% (Q4 2009), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 57.14
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 5.61
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 17.68
7 Evaxion A 62.56 Bn 62.54 Bn - -6.79
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.51
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 7.07
10 Kazia Therapeutics 1.55 Bn 1.55 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2011 0.65
Dec 31, 2011 0.65
Dec 31, 2010 0.19
Dec 31, 2010 0.19
Dec 31, 2009 0.02
Dec 31, 2009 0.02